Trevor, Stewart, Burton & Jacobsen’s Novartis NVS Stock Holding History

Trevor, Stewart, Burton & Jacobsen’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$247K	Sell	3,203 -78	-2%	-$6.2K	0.28%	44
2015 Q3	$270K	Sell	3,281 -18,749	-85%	-$1.67M	0.31%	38
2015 Q2	$1.94M	Sell	22,030 -20,423	-48%	-$1.87M	1.73%	27
2015 Q1	$3.75M	Buy	42,453 +39,384	+1,283%	+$3.49M	3.11%	19
2014 Q4	$223K	Sell	3,069 -54,450	-95%	-$4.51M	0.18%	42
2014 Q3	$4.85M	Buy	57,519 +12	+0%	+$971	3.1%	16
2014 Q2	$4.67M	Buy	+57,507	New	+$4.52M	2.42%	21

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Trevor, Stewart, Burton & Jacobsen's NVS Position: Q4 2015 in Review

Trevor, Stewart, Burton & Jacobsen reduced its Novartis (NVS) stake by 2.4% in Q4 2015, selling an estimated $6.2K and leaving 3,203 shares worth $247K. The position accounts for 0.28% of the portfolio, ranked #44.

Trevor, Stewart, Burton & Jacobsen first reported a position in NVS in Q2 2014 and has held it in 7 quarters since. The position peaked at $4.85M in Q3 2014. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Trevor, Stewart, Burton & Jacobsen held 3,203 shares of Novartis worth $247K as of Q4 2015.
Trevor, Stewart, Burton & Jacobsen sold 78 Novartis shares in Q4 2015, an estimated $6.2K.
Novartis made up 0.28% of Trevor, Stewart, Burton & Jacobsen's portfolio in Q4 2015, its #44 holding.
Trevor, Stewart, Burton & Jacobsen first reported a position in Novartis in Q2 2014 and has held it in 7 quarters since.
Trevor, Stewart, Burton & Jacobsen's Novartis position peaked at $4.85M in Q3 2014.
927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Trevor, Stewart, Burton & Jacobsen's 13F filing for Q4 2015, filed 12 Feb 2016.